Atlas Trials

Study of Tamoxifen Dose Escalation in Breast Cancer Patients With CYP2D6 Polymorphisms

Clinical trial NCT01075802 · COMPLETED

Trial details

NCT number
NCT01075802
Sponsor
Western Sydney Local Health District
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast CancerCYP2D6 Polymorphism
Start date
2010-03-01
Primary completion
2012-10-01
Enrollment
121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.